ReviewStereotactic and functional neurosurgery2025
Long-Term Ambulatory Intracranial EEG.
Review in Stereotactic and functional neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundLong-term ambulatory intracranial EEG is beginning to transform epilepsy care by revealing new insights into seizure patterns and treatment responses over the course of months to years. The feasibility of such monitoring was initially demonstrated through a dedicated recording system. Subsequently, brain-implanted neurostimulators became available with integrated recording functionality, revealing numerous clinically useful applications. SUMMARY: Chronic intracranial EEG allows long-term characterization of patient events, which can clarify which are epileptic, and also help identify unrecognized or subclinical seizures, which can vastly outnumber reported ones. Longitudinal recordings allow monitoring of epilepsy burden over the course of months to years, including responses to treatments such as neuromodulation and anti-seizure medications. Medication efficacy can be assessed in a matter of weeks rather than months. In patients with more than one potential localization, the predominant seizure focus can be identified, enabling further surgical options such as resection. Temporal patterns including circadian and multiday cycles may be revealed with the potential to enable temporal-specific treatments, seizure forecasts, and seizure warnings. Beyond direct clinical applications, ambulatory intracranial EEG has also opened up a new field of neuroscience in naturalistic environments. KEY MESSAGES: Long-term intracranial recordings have led to new discoveries about the individualized course of epilepsy and how it responds to treatment. They are clinically useful but are currently limited to patients with specific neurostimulators which are not available worldwide. Current systems allow long-term monitoring with intermittent EEG and/or hourly summary data but do not have continuous EEG availability. Expansion to patients without neurostimulators could provide broader clinical benefit. Scalp and implanted subscalp monitoring systems are now entering clinical care and may offer some of the same advantages as intracranial recording systems, although comparisons have not been made.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.